Last edition
News about "GLP-1 receptor agonists "
Yao Pharma and Pfizer Sign Exclusive Collaboration Deal
Yao Pharma has entered into an exclusive global licensing agreement with Pfizer, granting rights to develop, manufacture, and commercialise its oral small-molecule GLP-1 receptor agonists, including lead candidate YP05002. The partnership aims to advance next-generation metabolic therapies with worldwide reach.
GLP-1 Receptor Agonists | 10/12/2025 | By Akanki
BioMed X and Novo Nordisk Partner to Advance Oral Peptide Drug Delivery
BioMed X and Novo Nordisk’s partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides.
GLP-1 Receptor Agonists | 21/08/2025 | By Dineshwori | 507
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy